bioMérieux introduziert ENDOZYME® II GO

31.08.2018

Entwickelt von dem R&D-Team der Hyglos GmbH - a bioMérieux company

01 June, 2018

bioMérieux, a world leader in the field of industrial microbiological control, announces the launch of ENDOZYME® II GO, a new endotoxin test in the bioMérieux ENDONEXTTM range of recombinant horseshoe crab Factor C (rFC) assays. This new assay resulting from the combined expertise of bioMérieux in microbiology and Hyglos GmbH in endotoxin detection enables endotoxin testing in pharmaceutical grade water, injectable drugs and other pharmaceutical products. This new test allows an easy and fast workflow, and is particularly adapted to raw materials and final product testing.

Die Pressemitteilung in voller Länge finden Sie hier:

www.biomerieux-industry.com/biomerieux-launches-endozymer-ii-go-innovative-test-detection-endotoxins-pharmaceutical-microbiology